Showing results (2051-2060 of 2,107) with videos related to

Sort By:
Pageof 211
British Journal of Haematology|April 21, 2015
Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative dataSusan E Bates, Robin Eisch, Alexander Ling, et al.
Critical Care Medicine|August 12, 2016
Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock PhenotypeHector R Wong, Natalie Z Cvijanovich, Nick Anas, et al.
Blood|April 7, 2021
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registryDimitrios Giannis, Steven L Allen, James Tsang, et al.
Heart Rhythm|August 21, 2025
Concomitant Cryoballoon Pulmonary Vein and Posterior Wall Isolation In Persistent Atrial Fibrillation: Results from the Left Atrial Posterior Wall Isolation In Conjunction with Pulmonary Vein Isolation Using the Cryoballoon for Treatment of Persistent Atrial FibrilLation (PIVoTAL) IDE TrialArash Aryana, Deep K Pujara, Shelley L Allen, et al.
Critical Care Medicine|May 12, 2015
A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney InjuryHector R Wong, Natalie Z Cvijanovich, Nick Anas, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2020
Ex Vivo Cell Therapy by Ectopic Hepatocyte Transplantation Treats the Porcine Tyrosinemia Model of Acute Liver FailureClara T Nicolas, Robert A Kaiser, Raymond D Hickey, et al.
Cell Metabolism|March 5, 2015
Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistanceMichael J Kraakman, Helene L Kammoun, Tamara L Allen, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDACClaire M Pfeffer, Sydney J Clifford, Saadia A Karim, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
The pseudo-caspase FLIP(L) regulates cell fate following p53 activationAndrea Lees, Alexander J McIntyre, Nyree T Crawford, et al.
Frontiers in Oncology|July 29, 2022
Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic LeukemiaMatthew Kaufman, Xiao-Jie Yan, Wentian Li, et al.
Pageof 211